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Abstract
Context and background: People and health systems worldwide face serious challenges due to shifting disease
demographics, rising population demands and weaknesses in healthcare provision, including capacity shortages
and lack of impact of healthcare services. These multiple challenges, linked with the global push to achieve
universal health coverage, have made apparent the importance of investing in workforce development to improve
population health and economic well-being. In relation to medicines, health systems face challenges in terms of
access to needed medicines, optimising medicines use and reducing risk.
In 2017, the International Pharmaceutical Federation (FIP) published global policy on workforce development (‘the
Nanjing Statements’) that describe an envisioned future for professional education and training. The documents
make clear that expanding the pharmacy workforce benefits patients, and continually improving education and
training produces better clinical outcomes.
Aims and purpose: The opportunities for harnessing new technologies in pharmacy practice have been relatively
ignored. This paper presents a conceptual framework for analysing production methods, productivity and technology
in pharmacy practice that differentiates between dispensing and pharmaceutical care services. We outline a framework
that may be employed to study the relationship between pharmacy practice and productivity, shaped by educational
and technological inputs.
Method and results: The analysis is performed from the point of view of health systems economics. In relation to
pharmaceutical care (patient-oriented practice), pharmacists are service providers; however, their primary purpose is
not to deliver consultations, but to maximise the quantum of health gain they secure. Our analysis demonstrates that
‘technology shock’ is clearly beneficial compared with orthodox notions of productivity or incremental gain
implementations. Additionally, the whole process of providing professional services using ‘pharmaceutical care
technologies’ is governed by local institutional frames, suggesting that activities may be structured differently
in different places and countries.
Discussion and Conclusion: Addressing problems with medication use with the development of a
pharmaceutical workforce that is sufficient in quantity and competence is a long-term issue. As a result of this
analysis, there emerges a challenge about the profession’s relationship with existing and emerging technical
innovations. Our novel framework is designed to facilitate policy, education and research by providing an
analytical approach to service delivery. By using this approach, the profession could develop examples of good
practice in both developed and developing countries worldwide.
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Background
People and health systems worldwide face serious chal-
lenges due to shifting disease demographics, rising popu-
lation demands and weaknesses in healthcare provision
[1]. Health problems are further exacerbated by current
and projected global short-falls in health workers, espe-
cially in developing nations [2]. These multiple chal-
lenges, linked with the global push to achieve universal
health coverage and the United Nations Sustainable De-
velopment Goals, have made apparent the importance of
investing in workforce development to improve popula-
tion health and economic well-being [3, 4]. In relation to
pharmaceuticals, health systems face challenges in terms
of (i) guaranteeing access to needed drugs [5], (ii) ratio-
nalising medicines use [6] and (iii) avoiding harm from
adverse events [7]. For medicine systems to be strength-
ened, pharmaceutical education needs constant research,
development and evaluation. There is a pressing need to
better understand the relationships between production,
productivity and technology in pharmacy practice to in-
form professional policy, education and research.
Improving patient outcomes
In 2017, FIP published 67 statements on Pharmacy and
Pharmaceutical Sciences Education (‘the Nanjing State-
ments’) that describe an envisioned future for profes-
sional education and training [8]. Underpinning these
statements are the beliefs that (i) expanding the pharma-
ceutical workforce benefits patients and (ii) continually
improving education and training produces better clin-
ical results. This paper responds to these beliefs by out-
lining a framework that may be employed to study the
relationship between pharmacy practice and productiv-
ity, which is shaped by educational and technological in-
puts. In suggesting our approach, we make the following
key assumptions. First, there is a difference between ‘effi-
cacy’ and ‘effectiveness’ in the sense that products that
prove efficacious in clinical trials may differ in their
effectiveness when used in practice [9]. Closing or nar-
rowing the gap between efficacy and effectiveness may
provide more value from the use of medicines [9]. In
addition, there is support for the argument that gaps
resulting from drug-related problems—whether clinical
[10, 11] or economic [12–15]—can be identified, pre-
vented and solved by pharmacists through the provision
of pharmaceutical care [16].
Next, we assume that pharmacists can improve patient
outcomes by reducing the occurrence of adverse events.
For instance, pharmacy interventions can help reduce
medical errors amongst older patients. Finally, we as-
sume that pharmacists have a role in understanding and
managing the unintended consequences of medicines
use, which may also extend to handling the unwanted
effects of the adoption of novel technologies [17, 18].
Pharmacists are well-equipped to reduce the occurrence
of such side effects and to optimise medicines use. With
these assumptions in mind, we have developed a con-
ceptual framework for analysing the relationship be-
tween pharmacy practice and productivity.
Production and productivity
Currently, the pharmacy profession performs two distinct
types of activities: (i) medicine access and supply and (ii)
pharmaceutical care. As a form of production, dispensing
is an organisational process (fed by the physical inputs of
capital, labour and consumables) that responds to pre-
scribers by supplying requested medicines; prescribing is
the most common point in the system of medicine use
where errors occur, in both acute and ambulatory care set-
tings [10, 11]. In contrast, pharmaceutical care involves
decision-making about medicines therapy and planned
consultations between pharmacists, prescribers and pa-
tients that facilitate the aim of improving health outcomes
[19]. This paper presents a conceptual framework that
represents the two production processes and makes sug-
gestions for the conceptualisation of ‘productivity’ in each.
Methods
Professional vision
Pharmaceutical care was first envisaged as a professional
service offering [20]. By re-focusing, re-educating and re-
orientating, pharmacists would evolve into clinicians,
working face-to-face with patients and collaborating with
physicians on behalf of the patient. This way of thinking
evolved during the 1980s and 1990s, when the philoso-
phies of ‘knowledge-management’ and ‘portfolio-working’
encouraged professionals in many service industries to
develop their knowledge and skills to work in partnership
with many different clients, often on a fee-for-service
basis. Whilst the ideological environment encouraged
pharmacists to re-professionalise, the rest of the world
was responding to the computer revolution [21]. As a re-
sult, the opportunities for harnessing new technologies in
pharmacy practice have been relatively ignored. There is a
clear vision for pharmaceutical care, but less clarity about
the profession’s relationship with existing and emerging
technical innovations. This paper aims to help redress this
imbalance by providing a novel framework for analysing
the relationship between pharmacy practice and the in-
novative dispensing and pharmaceutical care technologies,
which may be used by policy-makers, researchers and ed-
ucators in the field.
Current literature
There is a small, but constant stream of published
studies that evaluate the impact of new technologies
on pharmacy practice and patient outcomes. We sug-
gest that pharmacy technologies be divided along the
Baines et al. Human Resources for Health  (2018) 16:51 Page 2 of 9
following lines, using classifications based upon the foun-
dational work of Goundrey-Smith. ‘Prescribing-dispensing
technologies’ include electronic health records, electronic
prescribing, the electronic transfer of prescriptions, robot-
ics and barcode dispensing. ‘Pharmaceutical care tech-
nologies’ include mobile health, telecare, monitoring
technologies and smart pumps. There is currently a need
for scoping reviews of the literature in these two groups.
An initial analysis suggests that most published studies in
these areas are either quantitative or qualitative evalua-
tions that test specific technologies in a pharmacy-related
setting. As a body of work, current studies fail to (i) model
technology as an integral feature of pharmacy practice, (ii)
link new technologies with production processes in dis-
pensing and pharmaceutical care and (iii) explain how
technological advances affect productivity in drug supply
and patient service provision. Given these failings, there is
a need for a novel framework that helps policy-makers,
educators and researchers conceptualise the relationships
between production, productivity and technology in phar-
macy practice. This framework must be applicable inter-
nationally across varying health care systems.
Results
Proposed framework
The purpose of this paper is to present a conceptual frame-
work for analysing production methods, productivity and
technology in pharmacy practice that differentiates be-
tween dispensing and pharmaceutical care services. The
analysis is performed from the point of view of health sys-
tems economics. Because the fundamentals of pharmacy
practice are analysed, our approach is applicable
internationally. ‘Plumbing diagrams’ are presented in the
sections below that show the main connections between
key elements in the processes for dispensing and
pharmaceutical care. The diagrams are designed to en-
hance our understanding of the structure of pharmacy
practice. To achieve the aims of the paper, we perform the
following tasks: First, we outline two heuristic models that
show the different processes employed for dispensing and
pharmaceutical care. Next, economic analysis is used to
represent the relationship between labour inputs and phar-
macy practice outputs and to demonstrate how a ‘technol-
ogy shock’ can spur improvement in levels of productivity.
Third, we present separate models for automated dispens-
ing and technology-enabled pharmacy, as a means of
showing how different technologies can influence profes-
sional practice. Fourth, we discuss the relationship between
education and technology and suggest that the future may
lie with ‘blended pharmacy practice’. Finally, we make
recommendations for further research and policy.
Production
‘Production’ may be defined as ‘the means of creating
specified outputs with specific inputs’. In the context of
pharmacy practice, two production processes generally
employed are (i) the supply and dispensing of requested
medicines and (ii) the generation of health-related
pharmaceutical care outputs. The sub-sections below
outline formal models for both.
Drug dispensing
Dispensing is a physical supply process. The relationship
between inputs and outputs is normally stable, predict-
able and easily controlled. Figure 1 is a conceptual repre-
sentation of the typical dispensing process. Demand,
usually in the form of paper-based prescriptions written
by practitioners, is shown on the left of the diagram.
The arrival of a prescription triggers a choice (shown by
the black square) to employ consumables (that is, the
Fig. 1 Manual dispensing process
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items used during dispensing, including computing, la-
belling, packaging and container costs) and staff time (in
terms of pharmacists and technicians) to operate the dis-
pensing process, which results in the supply of the re-
quested medicine. The diagram also shows that the use
of labour (L) and consumables (C) depends upon capital
(K) expenditure because levels of investment (for in-
stance, in barcode dispensing) affect how staff work and
associated dispensing costs. Throughout our framework,
L refers to any labour inputs used in the production
process and includes pharmacists, technicians and other
auxiliary staff. Finally, the dotted box around the edges
of Fig. 1 implies that individual dispensing processes are
influenced by the ‘institutional framework’ relevant to
their local pharmacy practice jurisdiction. An ‘institu-
tion’ may be defined as the ‘law, regulations, policy,
rules, conventions, ethics and norms governing behav-
iour’ [22]. In most countries, the institutions governing
dispensing are clearly defined in national law and profes-
sional codes of conduct. For instance, the requirement
that a pharmacist be present when medicines are sup-
plied will limit the ways in which production may be
organised. Therefore, dispensing processes may differ
between places with different institutional frames [23].
Pharmaceutical care
Pharmaceutical care has been adopted internationally as
an appropriate model of pharmacy practice. The board
of the Pharmaceutical Care Network Europe suggests
that ‘pharmaceutical care’ be defined as the ‘pharmacist’s
contribution to the care of individuals to optimise medi-
cines use and improve health outcomes’ [24]. Figure 2
reflects this definition. Starting from the left, needed
pharmaceutical care services are authorised by the rele-
vant payer, which triggers the choice to expend staff
time (usually a qualified pharmacist, but can include
other personnel) and related consumables (that is, the
materials required to perform a medicines review, for
example) to provide the requested service [25]. The
amount of labour and consumables expended depends
upon the level of capital expenditure (for instance,
spending on decision support software). As pharmaceut-
ical care is usually provided as a professional service, the
diagram includes a circle that represents the face-to-face
interaction between pharmacists and patients and con-
sultation with physicians. If personal consultations with
either or both are successful, the advice provided can
directly improve patient health outcomes, which is the
desired outcome of this philosophy of practice. Finally,
pharmaceutical care activities always occur within a gov-
erning institutional framework.
Productivity
‘Productivity’ may be defined as ‘the rate at which labour
inputs produce specific production outputs’. The rela-
tionship between these two variables may be represented
by the production function formula Y = f(L), where Y is
an output and L is the input of labour. This relationship
is represented diagrammatically for dispensing and
pharmaceutical care in the sub-sections below. We as-
sume that staff skills are part of the relationship f(L) and
that better skilled workforces will produce higher levels
of Y with the same labour inputs.
Dispensing productivity
Figure 3 shows the production relationship space for
labour inputs and the output of medicines dispensed,
Yd. The curve PF1 shows the relationship between L
(pharmacist and technician time) and the number of
items supplied. Its shape suggests ‘diminishing marginal
Fig. 2 Manual pharmaceutical care
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returns’ in the sense that, as more labour is employed,
more items are dispensed, but workers become less pro-
ductive per unit completed. At the level of labour input
L0 the dispensing volume supplied is Yd0. If more labour
is utilised, shifting the input from L0 to L1, then output
increases from Yd0 to Yd1. This is called a ‘shift along
the production function’. If the rate of productivity
shown by PF1 does not increase, then more labour must
be expended if dispensing volumes rise. If workers be-
come more productive (perhaps due to better training),
then a ‘shift in the production function’ may occur from
PF1 to PF2. As a result, labour input L1 can now produce
Yd2. If the production function shifts from PF1 to PF2
but dispensing volumes do not rise, then Yd0 may be
produced with L3 labour and Yd1 with L2. Figure 3
therefore shows that dispensing volumes may be in-
creased by (i) raising labour inputs, (ii) improving prod-
uctivity or (iii) a combination of both.
Pharmaceutical care productivity
Although pharmaceutical care pharmacists are service
providers, the primary purpose of their work is not to
deliver consultations, but to maximise the quantum of
health gain they secure. In other words, they focus on
patient outcomes not service outputs. Nevertheless, the
economic concept of productivity measures physical out-
puts not subsequent benefits secured by consumers.
Therefore, Fig. 4 shows the relationship between labour
inputs and pharmaceutical care outputs measured in
terms of services delivered, Ys, not health gains. Using
the normal economic assumption of diminishing mar-
ginal returns, PF1 shows the initial relationship between
L and Ys. At the level of labour input L0 the production
of services is Ys0. If more labour is expended at L1, then
output increases to Ys1. As workers become more pro-
ductive (for instance, due to education or training), the
production function shifts from PF1 to PF2. With the
new production function, L1 can produce Ys2. Although
all productivity gains are important, the improvement
from Ys1 to Ys2 is relatively marginal. In response, one
way of securing a substantial improvement in productiv-
ity is the introduction of an innovation that creates a
‘technology shock’. For instance, online telecare facilities
may greatly increase the number of services that phar-
macists in rural areas may complete per hour [26, 27].
The effects of such a shock are shown by PF3, which is a
major increase in productivity compared to PF2. With
this relatively substantial jump, L1 can now produce Ys3.
Alternatively, if Ys1 services are produced, PF1 requires
the input of L1 labour, PF2 requires L2 inputs and PF3 re-
quires L3. These responses demonstrate that the technol-
ogy shock is clearly beneficial compared with the
original level of productivity, PF1, or the incremental
gain, PF2. Therefore, we may conclude that technological
innovation can be vitally important to pharmacy practice
productivity.
Technology
‘Technology’ may be defined as the ‘dynamic clustering
of techniques, methods, skills and processes used in the
production of goods or services or in the achievement of
outcomes that deliver desired benefits for consumers’.
Our framework represents the different ways technology
and education can impact upon pharmacy practice and
productivity.
Prescribing-dispensing technologies
Figure 5 is a conceptualisation of an automated dispensing
process. Automated systems connect prescribers to the
dispensing process through a series of inter-related tech-
nologies. To successfully integrate, the process requires
interoperability between its separate data sources and soft-
ware programmes. In this automated system, demand is
generated by prescribers using electronic prescribing
Fig. 3 The dispensing production function
Fig. 4 The pharmaceutical care production function
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software and is received in the dispensary as electronically
transferred prescriptions. These electronic requests trigger
the use of consumables and staff time, which are either re-
leased manually (by an authorised decision-maker) or
automatically (within the system itself ). In our schema, re-
quested drugs are dispensed robotically, which may in-
volve staff resources when medicines are checked and
handed-over to patients. The level of human input
expended throughout the process will depend upon the
degree of automation, which (in turn) depends upon the
size of capital expenditure. As the diagram shows, details
of medicines supplied are recorded on electronic health
records, which are available for prescribers to review. The
prescribing-dispensing process is governed by local insti-
tutions that have special laws, regulations, policies, rules,
conventions, ethics and norms, which also legislate the
use of health technologies and patient data. As the auto-
mated process covers both drug choice and supply, we
refer to the technologies harnessed in this system as
prescribing-dispensing technologies.
Pharmaceutical care technologies
Figure 6 suggests how a fully integrated, technology-
enabled pharmaceutical care process could be struc-
tured. The diagram is more ‘normative’ (that is, ‘what
should be’) than ‘positive’ (that is, ‘what is’) because few
systems of this type yet exist. Starting on the left, deci-
sion support software identifies patients requiring a
medicine service, which is authorised before being sent
as a service request to a providing pharmacist. The sub-
sequent provision expends resources, primarily the ex-
penditure of pharmacist time during face-to-face or
phone consultations. During their interactions with pa-
tients and prescribers, the use of pharmaceutical care
technologies enables pharmacists to be more effective
and efficient at service provision. Alongside technology-
assisted, face-to-face consultations, patients can adopt
their own health technologies (such as mobile health
apps) to help manage their own health. Our framework,
therefore, differentiates between ‘technology-enabled
pharmacy’ and personalised health technologies. The
Fig. 5 Automated dispensing process
Fig. 6 Technology-enabled pharmaceutical care
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former is an approach to improving the effectiveness
and efficiency of service offerings. The latter are sold by
manufacturers directly to patients to monitor and to
help improve their own health. Working in partnership,
the combination of face-to-face consultations with phar-
macy and patient technologies could result in better
health outcomes, if the circumstances are favourable. To
help improve care choices, data (including services pro-
vided, technologies harnessed and patient health infor-
mation) are collected in electronic health records and
fed into the appropriate decision support systems. The
whole process of providing professional services using
‘pharmaceutical care technologies’ is governed by local
institutional frames, suggesting that activities may be
structured differently in different places and countries.
Discussion
The conceptual framework presented here suggests that
pharmacy practice and technology are often intimately
interconnected. Production processes for dispensing and
pharmaceutical care adopt technologies specifically de-
signed to secure their required outputs of, respectively,
medicines supplied and services provided.
Technology-enabled pharmacy
In 2009, the ASHP Section of Pharmacy Informatics and
Technology reported that pharmacy practice, especially
in the acute sector, had remained unchanged for over
30 years [28]. In response, the section argued that the
profession should focus less on drug distribution and
more on medicines use. This requires the adoption of
new models of practice and supporting technologies that
enable pharmacists to (i) reduce their input into the dis-
pensing process, (ii) improve their performance at pro-
viding professional services and (iii) secure better patient
outcomes [29]. In today’s environment, these reforms
could be achieved as follows. First, pharmacist involve-
ment in dispensing could be reduced by switching to
more automated processes, thus freeing time for other
activities [30]. For example, time would be available to
counsel patients on the proper use of their medicines.
Next, innovations could be adopted that enable pharma-
cists to provide their services more efficiently. For in-
stance, decision-support systems could improve the
screening of prescriptions and select patients suitable for
pharmaceutical care interventions; they can also be em-
bedded in computer prescriber order entry systems to
alert prescribers to potential errors when treatment deci-
sions are made, preventing errors proactively [31].
Finally, pharmacists could co-produce better health out-
comes by incorporating patient health technologies into
their work. For example, by having patients track and
trend biomarkers such as blood glucose in diabetics,
pharmacists can better monitor treatment outcomes. In
addition, utilising digital health and prescribing dispens-
ing technologies especially in low-resource settings
would potentially positively impact service and health
outcomes; already, existing services that improve medi-
cation adherence and access to medicines such as home
delivery services are being improved by technological ap-
plications that can help patients order and track their
deliveries. If these significant improvements are rigor-
ously pursued, future opportunities and boundaries of
pharmacy practice could be defined by emerging tech-
nologies rather than by the profession’s historically de-
fined roles [32].
As a caveat, the application of technology may
threaten a current pharmacy workforce by eliminating
some tasks currently performed by pharmacists. There
is also the implication that new skills may be needed in
the current and future pharmacy workforce to assume
the new roles that technology has the potential to en-
able. However, this framework does not address the
issue of workforce directly. In keeping with the main-
stream economics approach, we treat pharmacists as an
input (L) that is homogeneous and interchangeable.
Measuring the he response of an existing labour force
to changes in production is beyond the scope of this
framework at present. In many cases, an existing work-
force may be profoundly threatened by technological
change and may not be compliant or positive to imple-
mentation, which creates a serious threat to success. As
an economic framework, our approach does not en-
compass such matters. Nevertheless, we acknowledge
that the self-interest of the existing workforce is im-
portant subject for further study, perhaps through im-
plementation science or sociological studies.
Blended pharmacy practice
At the core of our conceptual framework is the assump-
tion that technology-enabled practice differs significantly
from traditional practice methods [33]. Based upon this
belief, we argue that improvements in productivity may
be achieved by (i) switching to technology-enabled prac-
tice, (ii) incremental changes with existing technologies
(for instance, due to re-training) and (iii) technology
shocks (such as the introduction of a radically better sys-
tems for delivering clinical outcomes). Despite the possi-
bilities that innovation offers, the current reality is that
most dispensing and pharmaceutical care activities are
not technologically advanced, with the slow adoption of
technologies of most types. This is not atypical given the
insight gained from the study of the diffusion of
innovation that shows a time frame of decades for new
ideas to be adopted [34] situation may be described
using Fig. 7. On the left, some face-to-face consultations
are delivered manually, with no technological support
whatsoever. In the middle, specific technologies exist
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that may be used to directly enable professional working.
On the right, patients may purchase their own health
technologies that, in suitable circumstances, supplement
the preceding approaches to service provision. In re-
sponse to this mixture of manual and technological pro-
cesses, we suggest that the term ‘blended pharmacy
practice’ should be used to describe the profession’s
working practices in the twenty-first century.
Education and technology
In 2017, FIP published a technical report, Transforming
Pharmacy and Pharmaceutical Sciences Education in the
Context of Workforce Development [8]. The work ac-
knowledges that, in response to the redefining concept
of pharmaceutical care, pharmacy practice has under-
gone a progressive shift from being primarily product-
oriented (in terms of medicines supply) to becoming
more patient-oriented (in terms of generating health
outcomes) [35]. With the aim of enhancing standards
worldwide, the document contains 67 statements on
Pharmacy and Pharmaceutical Sciences Education (‘the
Nanjing Statements’) that describe an envisioned future
for professional education and training. Nanjing State-
ment number 7.3 states that ‘policies and procedures
support regular review of the curriculum and allow de-
velopments in the curriculum to take place in a timely
manner so as to keep up with the changes in the profes-
sion, technology and society’. This statement clearly ac-
knowledges the intimate connection between pharmacy
practice, technology and patient behaviours. To support
workforce development, we suggest that ‘blended prac-
tice’ should now become a core concept in pharmacy
education, both for the existing and future pharmacy
workforce worldwide.
Conclusions
Technology has the potential to shape the nature and
values of pharmacy practice, with implications for pro-
fessional roles, power, jurisdictions and boundaries [36].
Our novel framework is designed to facilitate policy,
education and research by providing an analytical ap-
proach to service delivery. By using our approach, the
profession could develop examples of good practice in
both developed and developing countries worldwide. We
believe that this important policy agenda should be sup-
ported by the following research activities: (i) further
study of how the concept of technology applies to phar-
macy practice, (ii) scoping reviews of the literature on
technology-enablement in dispensing and pharmaceut-
ical care and (iii) high-quality qualitative and quantita-
tive evaluations of new technologies employed in a
pharmacy setting. Finally, we conclude that the profes-
sion should acknowledge the importance of technology
in determining the techniques, methods, skills and pro-
cesses embedded in dispensing and pharmaceutical care
practice. Addressing problems with medication use with
the development of a pharmaceutical workforce that is
sufficient in quantity and competence is a long-term
issue. As companion strategy, utilising technology to
make the healthcare system more efficient such that
there is less demand on workforce can be a shorter path
to improvement. Education and training programmes
will be essential to prepare the current and future phar-
macy workforce to realise the potential benefits of tech-
nology to improve the responsible use of medicines.
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